Skip to main content
Erschienen in: Endocrine Pathology 4/2015

01.12.2015

Hashimoto’s Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma

verfasst von: Husniye Baser, Didem Ozdemir, Neslihan Cuhaci, Cevdet Aydin, Reyhan Ersoy, Aydan Kilicarslan, Bekir Cakir

Erschienen in: Endocrine Pathology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The association between papillary thyroid carcinoma (PTC) and Hashimoto’s thyroiditis (HT) is controversial. In this study, we aimed to compare preoperative thyroid functions, ultrasonography (US) features, fine-needle aspiration biopsy (FNAB) results, and histopathological characteristics of PTC in patients with and without HT. Data of 919 PTC patients were reviewed retrospectively. The diagnosis of HT was based on histopathological examination and patients were grouped as HT and non-HT. There were 1321 PTC lesions in 919 patients among which 317 (34.5 %) had coexistent HT. There were no significant differences in nodule volume, longitudinal diameter, texture, echogenicity, marginal regularity, presence of microcalcification and hypoechoic halo, and peripheral vascularization in patients with and without HT (p > 0.05, for all parameters). Macrocalcification was observed more frequently in the non-HT group (p = 0.021). FNAB results were similar in the two groups (p = 0.105). Distribution of variants, capsule invasion, vascular invasion, and extrathyroidal extension were observed with similar rates in the HT and non-HT groups. Lymph node metastasis was significantly higher in patients without HT (p = 0.012). Of the carcinomas, 66.1 % (n = 874) were papillary thyroid microcarcinoma (PTMC). Tumor size was lower in PTMC lesions coexistent with HT (p = 0.026). We observed lower rates of capsule invasion, extrathyroidal extension, and lymph node metastases in PTMC with HT compared to without HT (p = 0.007, p = 0.003, and p = 0.015, respectively). This study showed that US features, FNAB results, and histopathological findings of PTC lesions are not influenced by the presence of HT. However, PTMC seems to be related with less aggressive histopathological behavior in HT.
Literatur
1.
Zurück zum Zitat Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70: 511–518CrossRefPubMed Mazzaferri EL, Young RL (1981) Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 70: 511–518CrossRefPubMed
2.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 (1998) Cancer 83:2638–2648CrossRefPubMed Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 (1998) Cancer 83:2638–2648CrossRefPubMed
3.
Zurück zum Zitat Guarino V, Castellone MD, Avilla E, Melillo RM (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 321:94–102CrossRefPubMed Guarino V, Castellone MD, Avilla E, Melillo RM (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 321:94–102CrossRefPubMed
4.
Zurück zum Zitat Tamimi DM (2002) The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141–146CrossRefPubMed Tamimi DM (2002) The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141–146CrossRefPubMed
5.
Zurück zum Zitat Schaffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, Schölmerich J, Rüschoff J (1998) Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 28:838–844CrossRefPubMed Schaffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, Schölmerich J, Rüschoff J (1998) Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 28:838–844CrossRefPubMed
6.
Zurück zum Zitat Antonaci A, Consorti F, Mardente S, Giovannone G (2009) Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res 17:495–503CrossRefPubMed Antonaci A, Consorti F, Mardente S, Giovannone G (2009) Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res 17:495–503CrossRefPubMed
7.
Zurück zum Zitat Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107:95–100CrossRefPubMed Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL (1997) Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107:95–100CrossRefPubMed
8.
Zurück zum Zitat Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL (2002) Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112:238–242CrossRefPubMed Cornetta AJ, Russell JP, Cunnane M, Keane WM, Rothstein JL (2002) Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112:238–242CrossRefPubMed
9.
Zurück zum Zitat Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tmai H (1995) The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421–3424PubMed Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tmai H (1995) The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421–3424PubMed
10.
Zurück zum Zitat Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458–463CrossRefPubMed Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458–463CrossRefPubMed
11.
Zurück zum Zitat Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP (1999) Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070–1076CrossRefPubMed Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP (1999) Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070–1076CrossRefPubMed
12.
Zurück zum Zitat Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5.PubMed Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M (2008) The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5.PubMed
13.
Zurück zum Zitat Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450–456CrossRefPubMed Jo VY, Stelow EB, Dustin SM, Hanley KZ (2010) Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol 134:450–456CrossRefPubMed
14.
Zurück zum Zitat Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165CrossRefPubMed Cibas ES, Ali SZ (2009) The Bethesda System for Reporting Thyroid Cytopathology. Thyroid 19:1159–1165CrossRefPubMed
15.
Zurück zum Zitat Weetman AP (2004) Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 61:405–413CrossRef Weetman AP (2004) Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 61:405–413CrossRef
16.
Zurück zum Zitat Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA (2005) Hashimoto thyroiditis coexistent with papillary carcinoma. Am Surg 71:874–878PubMed Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA (2005) Hashimoto thyroiditis coexistent with papillary carcinoma. Am Surg 71:874–878PubMed
17.
Zurück zum Zitat Larson SD, Jackson L, Riall T, Uchida T, Thomas RP, Qiu S, Evers BM (2007) Increased incidence of well-differentiated thyroid cancer associated with Hashimoto’s thyroiditis and the role of the PI3K/AKT pathway. J Am Coll Surg 204:764–775PubMedCentralCrossRefPubMed Larson SD, Jackson L, Riall T, Uchida T, Thomas RP, Qiu S, Evers BM (2007) Increased incidence of well-differentiated thyroid cancer associated with Hashimoto’s thyroiditis and the role of the PI3K/AKT pathway. J Am Coll Surg 204:764–775PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Erdogan M, Erdem N, Cetinkalp S, Ozgen AG, Saygılı F, Yilmaz C, Tuzun M, Kabalak T (2009) Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: a result of a university hospital of 769 patients in Turkey. Endocrine 36:486–490CrossRefPubMed Erdogan M, Erdem N, Cetinkalp S, Ozgen AG, Saygılı F, Yilmaz C, Tuzun M, Kabalak T (2009) Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto’s thyroiditis: a result of a university hospital of 769 patients in Turkey. Endocrine 36:486–490CrossRefPubMed
19.
Zurück zum Zitat Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H (2008) Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 150:49–52PubMedCentralCrossRefPubMed Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H (2008) Is Hashimoto’s thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 150:49–52PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Anil C, Goksel S, Gursoy A (2010) Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20:601–606CrossRefPubMed Anil C, Goksel S, Gursoy A (2010) Hashimoto’s thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20:601–606CrossRefPubMed
21.
Zurück zum Zitat Matesa-Anic’ D, Matesa N, Dabelic’ N, Kusic’ Z (2009) Coexistence of papillary carcinoma and Hashimoto’s thyroiditis. Acta Clin Croat 48:9–12. Matesa-Anic’ D, Matesa N, Dabelic’ N, Kusic’ Z (2009) Coexistence of papillary carcinoma and Hashimoto’s thyroiditis. Acta Clin Croat 48:9–12.
22.
Zurück zum Zitat Bradly D, Reddy V, Prinz RA, Gattuso P (2009) Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146:1099–1104CrossRefPubMed Bradly D, Reddy V, Prinz RA, Gattuso P (2009) Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 146:1099–1104CrossRefPubMed
23.
Zurück zum Zitat Kwak HY, Chae BJ, eom YH, Hong YR, Seo JB, Lee SH, Song BJ, Jung SS, Bae JS (2015) Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol 20:463–473CrossRefPubMed Kwak HY, Chae BJ, eom YH, Hong YR, Seo JB, Lee SH, Song BJ, Jung SS, Bae JS (2015) Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol 20:463–473CrossRefPubMed
24.
Zurück zum Zitat Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148:396–402CrossRefPubMed Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S, Zhang J (2013) Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148:396–402CrossRefPubMed
25.
Zurück zum Zitat Tae HJ, Lim DJ, Baek KH, Park WC, Lee YS, Choi JE, Lee JM, Kang MI, Cha BY, Son HY, Lee KW, Kang SK (2007) Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 17: 461–466CrossRefPubMed Tae HJ, Lim DJ, Baek KH, Park WC, Lee YS, Choi JE, Lee JM, Kang MI, Cha BY, Son HY, Lee KW, Kang SK (2007) Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. Thyroid 17: 461–466CrossRefPubMed
26.
Zurück zum Zitat Solbiati L, Livraghi T, Ballarati E, et al. (1995) Thyroid gland. In: Solbiati L, Rizzatto G. Ultrasound of Superficial Structure: London: Churchill, Livingstone, 45: 85, 1995 SA ed. Thyroid disease: Endocrinology, Surgery, Nuclear Medicine and Radiology Lippincott-Raven, Philadelphia, 65–104 Solbiati L, Livraghi T, Ballarati E, et al. (1995) Thyroid gland. In: Solbiati L, Rizzatto G. Ultrasound of Superficial Structure: London: Churchill, Livingstone, 45: 85, 1995 SA ed. Thyroid disease: Endocrinology, Surgery, Nuclear Medicine and Radiology Lippincott-Raven, Philadelphia, 65–104
27.
Zurück zum Zitat LiVolsi VA (1997) Pathology of thyroid disease. In: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiology, Falk SA, Eds. Lippincott-Raven, Philadelphia, 65–104 LiVolsi VA (1997) Pathology of thyroid disease. In: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine and Radiology, Falk SA, Eds. Lippincott-Raven, Philadelphia, 65–104
28.
Zurück zum Zitat Yeh HC, Futterweit W, Gilbert P (1996) Micronodulation: ultrasonographic sign of Hashimoto Thyroiditis. J Ultrasound Med 15: 813–819PubMed Yeh HC, Futterweit W, Gilbert P (1996) Micronodulation: ultrasonographic sign of Hashimoto Thyroiditis. J Ultrasound Med 15: 813–819PubMed
29.
Zurück zum Zitat Trimboli P, Nasrollah N, Amendola S, Rossi F, Ramacciato G, Romanelli F, Aurella P, Crescenzi A, Laurenti O, Condorelli E, Ventura C, Valabrega S (2012) Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocr J 59:503–508CrossRefPubMed Trimboli P, Nasrollah N, Amendola S, Rossi F, Ramacciato G, Romanelli F, Aurella P, Crescenzi A, Laurenti O, Condorelli E, Ventura C, Valabrega S (2012) Should we use ultrasound features associated with papillary thyroid cancer in diagnosing medullary thyroid cancer? Endocr J 59:503–508CrossRefPubMed
30.
Zurück zum Zitat Das DK, Sheikh ZA, George SS, Al-Baquer T, Francis IM (2008) Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol 36:809–812CrossRefPubMed Das DK, Sheikh ZA, George SS, Al-Baquer T, Francis IM (2008) Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol 36:809–812CrossRefPubMed
31.
Zurück zum Zitat Kim EK, Parl CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS (2002) New sonographic criteria for recommends fine-needle aspiration biopsy of nonpalpable solid nodule of the thyroid. A JR Am J Roentgenol 178:687–691CrossRef Kim EK, Parl CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS (2002) New sonographic criteria for recommends fine-needle aspiration biopsy of nonpalpable solid nodule of the thyroid. A JR Am J Roentgenol 178:687–691CrossRef
32.
Zurück zum Zitat Ohmori N, Miyakawa M, ohmori K, Takano K (2007) Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto’s thyroiditis. Intern Med 46:547–550CrossRefPubMed Ohmori N, Miyakawa M, ohmori K, Takano K (2007) Ultrasonographic findings of papillary thyroid carcinoma with Hashimoto’s thyroiditis. Intern Med 46:547–550CrossRefPubMed
33.
Zurück zum Zitat Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR (1997) Hashimoto’s thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol 16:531–536.CrossRefPubMed Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR (1997) Hashimoto’s thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol 16:531–536.CrossRefPubMed
34.
Zurück zum Zitat Ravinsky E, Safneck JR (1988) Differentiation of Hashimoto’s thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 32:854–861PubMed Ravinsky E, Safneck JR (1988) Differentiation of Hashimoto’s thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol 32:854–861PubMed
35.
Zurück zum Zitat Kumarasinghe MP, De Silva S (1999) Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology 31:1–7CrossRefPubMed Kumarasinghe MP, De Silva S (1999) Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology 31:1–7CrossRefPubMed
36.
Zurück zum Zitat Spencer CA (2011) Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615–3627CrossRefPubMed Spencer CA (2011) Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab 96:3615–3627CrossRefPubMed
37.
Zurück zum Zitat Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T (2014) Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol 21:2725–2732CrossRefPubMed Vasileiadis I, Boutzios G, Charitoudis G, Koukoulioti E, Karatzas T (2014) Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma. Ann Surg Oncol 21:2725–2732CrossRefPubMed
38.
Zurück zum Zitat Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC (2014) Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid 24:1107–1114PubMedCentralCrossRefPubMed Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC (2014) Hashimoto’s thyroiditis pathology and risk for thyroid cancer. Thyroid 24:1107–1114PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinoloaryngol 269:1013–1017CrossRef Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinoloaryngol 269:1013–1017CrossRef
40.
Zurück zum Zitat Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol 168:343–349CrossRefPubMed Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto’s thyroiditis: a meta-analysis. Eur J Endocrinol 168:343–349CrossRefPubMed
42.
Zurück zum Zitat Roti E, delgi Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673CrossRefPubMed Roti E, delgi Uberti EC, Bondanelli M, Braverman LE (2008) Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol 159:659–673CrossRefPubMed
44.
Zurück zum Zitat Lee HS, Park HS, Kim SW, Choi G, Park HS, Hong JC, Lee SG, Baek SM, Lee KD (2013) Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch otorhinolaryngol 270:2969–2974CrossRefPubMed Lee HS, Park HS, Kim SW, Choi G, Park HS, Hong JC, Lee SG, Baek SM, Lee KD (2013) Clinical characteristics of papillary thyroid microcarcinoma less than or equal to 5 mm on ultrasonography. Eur Arch otorhinolaryngol 270:2969–2974CrossRefPubMed
45.
Zurück zum Zitat Page C, Biet A, Boute P, Cuvelier P, Strunski V (2009) ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol 266:1959–1963CrossRefPubMed Page C, Biet A, Boute P, Cuvelier P, Strunski V (2009) ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol 266:1959–1963CrossRefPubMed
46.
Zurück zum Zitat Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, et al. (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043–1048CrossRefPubMed Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, et al. (2009) Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043–1048CrossRefPubMed
47.
Zurück zum Zitat Mantinan B, Rego-Iraeta A, Larranaga A, Fluiters E, Sanchez-Sobrino P, Garcia-Mayor RV (2012) Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res 2012:469397PubMedCentralCrossRefPubMed Mantinan B, Rego-Iraeta A, Larranaga A, Fluiters E, Sanchez-Sobrino P, Garcia-Mayor RV (2012) Factors influencing the outcome of patients with incidental papillary thyroid microcarcinoma. J Thyroid Res 2012:469397PubMedCentralCrossRefPubMed
48.
Zurück zum Zitat Gallo M, Pesenti M, Valcavi R (2003) Ultrasound thyroid nodule measurement: the “gold standard” and its limitations in clinical decision making. Endocr Pract 9:194–199CrossRefPubMed Gallo M, Pesenti M, Valcavi R (2003) Ultrasound thyroid nodule measurement: the “gold standard” and its limitations in clinical decision making. Endocr Pract 9:194–199CrossRefPubMed
49.
Zurück zum Zitat Hegedüs L (1990) Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 37:249–263PubMed Hegedüs L (1990) Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 37:249–263PubMed
50.
Zurück zum Zitat Knudsen N, Bols B, Bülow I, Jørgensen T, Perrild H, Ovesen L, Laurberg P (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069–1074CrossRefPubMed Knudsen N, Bols B, Bülow I, Jørgensen T, Perrild H, Ovesen L, Laurberg P (1999) Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid 9:1069–1074CrossRefPubMed
51.
Zurück zum Zitat Baloch ZW, LiVolsi VA (1999) Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311–316PubMed Baloch ZW, LiVolsi VA (1999) Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311–316PubMed
52.
Zurück zum Zitat Yoon YH, Kwon KR, Kwak SY, Ryu KA, Choi B, Kim JM, Koo BS (2014) Tumor size measured by preoperative ultrasonography and postoperative pathologic examination in papillary thyroid carcinoma: relative differences according to size, calcification and coexisting thyroiditis. Eur Arch Otorhinolaryngol 271:1235–1239CrossRefPubMed Yoon YH, Kwon KR, Kwak SY, Ryu KA, Choi B, Kim JM, Koo BS (2014) Tumor size measured by preoperative ultrasonography and postoperative pathologic examination in papillary thyroid carcinoma: relative differences according to size, calcification and coexisting thyroiditis. Eur Arch Otorhinolaryngol 271:1235–1239CrossRefPubMed
53.
Zurück zum Zitat Bachar G, Buda I, Cohen M, Hadar T, Hilly O, Schwartz N, Shpitzer T, Segal K (2013) Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma. Eur J Radiol 82: 1899–1903CrossRefPubMed Bachar G, Buda I, Cohen M, Hadar T, Hilly O, Schwartz N, Shpitzer T, Segal K (2013) Size discrepancy between sonographic and pathological evaluation of solitary papillary thyroid carcinoma. Eur J Radiol 82: 1899–1903CrossRefPubMed
54.
Zurück zum Zitat Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R (2009) BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977–2982PubMedCentralCrossRefPubMed Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R (2009) BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977–2982PubMedCentralCrossRefPubMed
55.
Zurück zum Zitat Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L (2013) BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 20:47–52CrossRefPubMed Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L (2013) BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 20:47–52CrossRefPubMed
Metadaten
Titel
Hashimoto’s Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma
verfasst von
Husniye Baser
Didem Ozdemir
Neslihan Cuhaci
Cevdet Aydin
Reyhan Ersoy
Aydan Kilicarslan
Bekir Cakir
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Endocrine Pathology / Ausgabe 4/2015
Print ISSN: 1046-3976
Elektronische ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-015-9401-8

Weitere Artikel der Ausgabe 4/2015

Endocrine Pathology 4/2015 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …